Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth Lederman

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Psychiatry Research|February 13, 2024
A phase 3, randomized, placebo-controlled, trial to evaluate the efficacy and safety of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related posttraumatic stress disorderMegan E Parmenter, Seth Lederman, Frank W Weathers, et al.
Viruses|October 28, 2023
Immunogenicity and Tolerability of a SARS-CoV-2 TNX-1800, a Live Recombinant Poxvirus Vaccine Candidate, in Syrian Hamsters and New Zealand White RabbitsMayanka Awasthi, Anthony Macaluso, Scott J Goebel, et al.
Psychiatry Research|May 12, 2021
Randomized clinical trial of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related PTSD and the role of sleep quality in treatment responseGregory M Sullivan, R Michael Gendreau, Judith Gendreau, et al.
Viruses|February 28, 2023
Single Dose of Recombinant Chimeric Horsepox Virus (TNX-801) Vaccination Protects Macaques from Lethal Monkeypox ChallengeRyan S Noyce, Landon W Westfall, Siobhan Fogarty, et al.
Vaccines|November 25, 2023
Immunogenicity and Efficacy of TNX-1800, A Live Virus Recombinant Poxvirus Vaccine Candidate, against SARS-CoV-2 Challenge in Nonhuman PrimatesMayanka Awasthi, Anthony Macaluso, Dawn Myscofski, et al.
Transplantation|January 10, 2025
Enhanced Costimulation Blockade With αCD154, αCD2, and αCD28 to Promote Heart Allograft Tolerance in Nonhuman PrimatesRyan Chaban, Ikechukwu Ileka, Kohei Kinoshita, et al.
Microorganisms|August 29, 2024
High-Throughput Screening Assay for Convalescent Sera in COVID-19: Efficacy, Donor Selection, and Variant NeutralizationKrishna P Kota, Ilya Trakht, Gavreel Kalantarov, et al.
Xenotransplantation|April 22, 2024
Novel factors potentially initiating acute antibody-mediated rejection in pig kidney xenografts despite an efficient immunosuppressive regimenKohei Kinoshita, Akihiro Maenaka, Ivy A Rosales, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 8, 2023
TNX-1500, a crystallizable fragment-modified anti-CD154 antibody, prolongs nonhuman primate cardiac allograft survivalShuhei Miura, Zahra A Habibabady, Franziska Pollok, et al.
Antiviral Research|January 2, 2023
Development of a rapid image-based high-content imaging screening assay to evaluate therapeutic antibodies against the monkeypox virusKrishna P Kota, Natasza E Ziółkowska, Jiayi Wei, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Psychiatry Research|February 13, 2024
A phase 3, randomized, placebo-controlled, trial to evaluate the efficacy and safety of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related posttraumatic stress disorderMegan E Parmenter, Seth Lederman, Frank W Weathers, et al.
Viruses|October 28, 2023
Immunogenicity and Tolerability of a SARS-CoV-2 TNX-1800, a Live Recombinant Poxvirus Vaccine Candidate, in Syrian Hamsters and New Zealand White RabbitsMayanka Awasthi, Anthony Macaluso, Scott J Goebel, et al.
Psychiatry Research|May 12, 2021
Randomized clinical trial of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related PTSD and the role of sleep quality in treatment responseGregory M Sullivan, R Michael Gendreau, Judith Gendreau, et al.
Viruses|February 28, 2023
Single Dose of Recombinant Chimeric Horsepox Virus (TNX-801) Vaccination Protects Macaques from Lethal Monkeypox ChallengeRyan S Noyce, Landon W Westfall, Siobhan Fogarty, et al.
Vaccines|November 25, 2023
Immunogenicity and Efficacy of TNX-1800, A Live Virus Recombinant Poxvirus Vaccine Candidate, against SARS-CoV-2 Challenge in Nonhuman PrimatesMayanka Awasthi, Anthony Macaluso, Dawn Myscofski, et al.
Transplantation|January 10, 2025
Enhanced Costimulation Blockade With αCD154, αCD2, and αCD28 to Promote Heart Allograft Tolerance in Nonhuman PrimatesRyan Chaban, Ikechukwu Ileka, Kohei Kinoshita, et al.
Microorganisms|August 29, 2024
High-Throughput Screening Assay for Convalescent Sera in COVID-19: Efficacy, Donor Selection, and Variant NeutralizationKrishna P Kota, Ilya Trakht, Gavreel Kalantarov, et al.
Xenotransplantation|April 22, 2024
Novel factors potentially initiating acute antibody-mediated rejection in pig kidney xenografts despite an efficient immunosuppressive regimenKohei Kinoshita, Akihiro Maenaka, Ivy A Rosales, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 8, 2023
TNX-1500, a crystallizable fragment-modified anti-CD154 antibody, prolongs nonhuman primate cardiac allograft survivalShuhei Miura, Zahra A Habibabady, Franziska Pollok, et al.
Antiviral Research|January 2, 2023
Development of a rapid image-based high-content imaging screening assay to evaluate therapeutic antibodies against the monkeypox virusKrishna P Kota, Natasza E Ziółkowska, Jiayi Wei, et al.
Pageof 3